Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dexmedetomidine Administration on the Success of Reconstructive Microsurgery in Cancer Patients: A Study of Glycocalyx Integrity, Inflammatory Response, Thrombosis, Angiogenesis, Oxidative Stress, and Tissue Microcirculation

NCT06993740 is registered in ClinicalTrials.gov with Dharmais National Cancer Center Hospital as lead sponsor.

NCT NCT06993740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06993740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dexmedetomidine Administration on the Success of Reconstructive Microsurgery in Cancer Patients: A Study of Glycocalyx Integrity, Inflammatory Response, Thrombosis, Angiogenesis, Oxidative Stress, and Tissue Microcirculation
Lead sponsor
Dharmais National Cancer Center Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 10, 2025
Completion date
March 8, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, flap failure risk factors, flap ischemia, flap monitoring, flap necrosis, glycocalyx, inflammation, microsurgery, oxidative stress, surgery, thrombosis